TALISMAN

Aventis Pharma Sa

Application Filed: 2003-01-21
Trademark Application Details
Trademark Logo TALISMAN

Mark For: TALISMAN® trademark registration is intended to cover the categories of scientific research and development; medical research; research and development relating to pharmaceutical preparations; clinical trial services namely, design and implementation of clinical trials; medical and scientific research, namely, conducting clinical trials; collection of data derived from clinical trials; testing of pharmaceutical preparations for the treatment of cardiovascular, arterial and arteriovenous circulatory disorders, peripheral arterial disease, and other related conditions; advisory and consultancy services relating to all the aforesaid services. [all]

Status

2022-07-02 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76483857
Registration Number3147095
Mark Literal ElementsTALISMAN
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeSERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2006-09-26
Basis44(e)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Domestic RepresentativeFinnegan, Henderson, Farabow, Garrett & Dunner, L.L.
Attorney NameB. Brett Heavner
Attorney Docket Number0888.0553
Law Office AssignedL70
Employee NameHOFFMAN, DAVID AARON

Timeline

2003-01-21Application Filed
2006-07-04Published
2006-07-04Published for Opposition
2006-09-26Location: PUBLICATION AND ISSUE SECTION
2006-09-26Trademark Registered
2013-05-03Cancelled
2013-05-03Status: Dead/Cancelled
2013-05-03Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: AVENTIS PHARMA SA
Address20 AVENUE RAYMOND ARON 92160 ANTONY FRANCE
Legal Entity TypeCorporation
Legal Entity StateFRANCE

Documents

ApplicationIMAGE/TIFF2003-01-21
DrawingIMAGE/TIFF2003-01-21
Offc Action OutgoingAPPLICATION/XML,IMAGE/JPEG2003-07-03
XSearch Search SummaryIMAGE/TIFF2003-07-03
Paper Correspondence IncomingIMAGE/TIFF2003-12-30
Suspension LetterAPPLICATION/XML2004-01-23
Offc Action OutgoingAPPLICATION/XML,IMAGE/JPEG2005-01-28
Paper Correspondence IncomingIMAGE/TIFF,IMAGE/JPEG2005-07-13
Offc Action OutgoingAPPLICATION/XML,IMAGE/JPEG2005-07-29
Paper Correspondence IncomingIMAGE/TIFF2005-11-08
Reconsideration LetterAPPLICATION/XML2005-12-19
Examiners AmendmentAPPLICATION/XML2006-05-02
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/TIFF2006-05-06
Notice of PublicationAPPLICATION/XML2006-06-14
Registration CertificateIMAGE/TIFF2006-09-26

Attorney of Record

FINNEGAN HENDERSON FARABOW GARRETT ET AL
901 NEW YORK AVE NW
WASHINGTON DC 20001-4413


Good, Services, and Codes

(CANCELLED)
IC 042. US 100 101. G & S: Scientific research and development; medical research; research and development relating to pharmaceutical preparations; clinical trial services namely, design and implementation of clinical trials; medical and scientific research, namely, conducting clinical trials; collection of data derived from clinical trials; testing of pharmaceutical preparations for the treatment of cardiovascular, arterial and arteriovenous circulatory disorders, peripheral arterial disease, and other related conditions; advisory and consultancy services relating to all the aforesaid services(CANCELLED)
IC 044. US 100 101. G & S: Medical services, namely, the treatment of cardiovascular arterial and arteriovenous circulatory disorders, peripheral arterial disease, cancer, central nervous system diseases and disorders, neurological disorders, musculoskeletal disorders, allergies, hypertension, stroke, inflammation, and inflammatory diseases; medical diagnostic services, namely, conducting genetic testing to identify medical conditions and diseases; compilation and preparation of medical reports; advisory and consultancy services relating to cardiovascular arterial and arteriovenous circulatory disorders, peripheral arterial disease, and other related conditions

International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0421Scientific research and development; medical research; research and development relating to pharmaceutical preparations; clinical trial services namely, design and implementation of clinical trials; medical and scientific research, namely, conducting clinical trials; collection of data derived from clinical trials; testing of pharmaceutical preparations for the treatment of cardiovascular, arterial and arteriovenous circulatory disorders, peripheral arterial disease, and other related conditions; advisory and consultancy services relating to all the aforesaid services

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2013-05-03
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2010-12-09
REGISTERED-PRINCIPAL REGISTER2006-09-26
EXPARTE APPEAL TERMINATED2006-09-26483857
PUBLISHED FOR OPPOSITION2006-07-04
NOTICE OF PUBLICATION2006-06-14
LAW OFFICE PUBLICATION REVIEW COMPLETED2006-05-1274221
ASSIGNED TO LIE2006-05-1274221
APPROVED FOR PUB - PRINCIPAL REGISTER2006-05-05
EXAMINERS AMENDMENT MAILED2006-05-03
EXAMINERS AMENDMENT -WRITTEN2006-05-0281855
EXAMINER'S AMENDMENT ENTERED2006-05-0288888
JURISDICTION RESTORED TO EXAMINING ATTORNEY2006-04-24483857
EX PARTE APPEAL-INSTITUTED2006-01-31483857
ACTION DENYING REQ FOR RECON MAILED2005-12-19
ACTION CONTINUING FINAL - COMPLETED2005-12-1981855
ASSIGNED TO EXAMINER2005-11-2981855
AMENDMENT FROM APPLICANT ENTERED2005-11-2168552
PAPER RECEIVED2005-11-08
CORRESPONDENCE RECEIVED IN LAW OFFICE2005-11-0868552
FINAL REFUSAL WRITTEN2005-07-2972505
FINAL REFUSAL MAILED2005-07-29
AMENDMENT FROM APPLICANT ENTERED2005-07-2073793
PAPER RECEIVED2005-07-13
CORRESPONDENCE RECEIVED IN LAW OFFICE2005-07-1373793
NON-FINAL ACTION WRITTEN2005-01-2872505
NON-FINAL ACTION MAILED2005-01-28
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2004-07-28
LETTER OF SUSPENSION MAILED2004-01-26
PAPER RECEIVED2003-12-30
CORRESPONDENCE RECEIVED IN LAW OFFICE2003-12-30
NON-FINAL ACTION MAILED2003-07-08
ASSIGNED TO EXAMINER2003-07-0272505

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed